The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology
Abstract:Smith G, Malla A, Williams R, Kopala L, Love L, Balshaw R. The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology.
Acta Psychiatr Scand 2006: 113 (Suppl. 430): 4–11. © 2006 Blackwell Munksgaard. Objective:
The Canadian National Outcomes Measurement Study in Schizophrenia (CNOMSS) is a prospective survey of routine clinical practice. Method:
Patients with schizophrenia or a related disorder were consecutively enrolled from all regions of Canada. Both academic and community psychiatric clinics were included and patients were followed up for 2 years. Clinical and functional status, quality of life, medication and economic costs were assessed at enrollment and monitored throughout the follow-up period. Results:
Patients attending an academic clinic tended to be younger and more severely ill than those from community clinics. Both types of sites prescribed atypical neuroleptics to more than three-quarters of the patients. The majority of those enrolled were unemployed and living in poverty. Poor clinical status was associated with poverty. Conclusion:
The CNOMSS provides demographic, clinical and treatment-related information about a large Canada-wide sample of psychiatric patients. The following three articles in this issue of Acta Psychiatrica Scandinavica explore issues related to medication, quality of life and resource utilization.
Document Type: Research Article
Publication date: May 1, 2006